» Articles » PMID: 18486908

Ursolic Acid Induces Apoptosis by Activating P53 and Caspase-3 Gene Expressions and Suppressing NF-kappaB Mediated Activation of Bcl-2 in B16F-10 Melanoma Cells

Overview
Date 2008 May 20
PMID 18486908
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study was to assess the effect of ursolic acid, a triterpene on inducing apoptosis in B16F-10 melanoma cells. Treatment of B16F-10 cells with nontoxic concentration of ursolic acid showed the presence of apoptotic bodies and induced DNA fragmentation in a dose depended manner. The apoptotic genes p53 and caspase-3 were found to be upregulated while the anti-apoptotic gene bcl-2 was down regulated in ursolic acid treated cells. The transcription factors NF-kappaBp65, NF-kappaBp50, NF-kappaBc-Rel, c-FOS, ATF-2 and CREB-1 were found to be inhibited significantly (p<0.001) in ursolic acid treated cells compared to untreated control. The pro-inflammatory cytokine production and gene expression of TNF-alpha, IL-1beta, IL-6 and GM-CSF were down regulated in ursolic acid treated cells compared to nontreated B16F-10 metastatic melanoma cells. All these results demonstrate that ursolic acid induce apoptosis via inhibition of NF-kappaB induced bcl-2 mediated anti-apoptotic pathway and subsequent activation of p53 mediated and TNF-alpha induced caspase-3 mediated pro-apoptotic pathways.

Citing Articles

Ursolic Acid as a Protective Agent against UVB-Induced Metabolic and Epigenetic Alterations in Human Skin Keratinocytes: An Omics-Based Study.

Li S, Li Z, Kuo H, Kong A Cancer Prev Res (Phila). 2024; 18(3):135-144.

PMID: 39718470 PMC: 11875927. DOI: 10.1158/1940-6207.CAPR-24-0441.


Complex Inhibitory Activity of Pentacyclic Triterpenoids against Cutaneous Melanoma In Vitro and In Vivo: A Literature Review and Reconstruction of Their Melanoma-Related Protein Interactome.

Moralev A, Zenkova M, Markov A ACS Pharmacol Transl Sci. 2024; 7(11):3358-3384.

PMID: 39539268 PMC: 11555519. DOI: 10.1021/acsptsci.4c00422.


: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity.

Medeiros M, Guenka S, Bastos D, Oliveira K, Brassesco M Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931401 PMC: 11206879. DOI: 10.3390/ph17060734.


The Emerging Role of Natural Products in Cancer Treatment.

Ghosh S, Kumar Das S, Sinha K, Ghosh B, Sen K, Ghosh N Arch Toxicol. 2024; 98(8):2353-2391.

PMID: 38795134 DOI: 10.1007/s00204-024-03786-3.


The Anticancer Activities of Natural Terpenoids That Inhibit Both Melanoma and Non-Melanoma Skin Cancers.

Yoon Y, Jung Y, Lee S Int J Mol Sci. 2024; 25(8).

PMID: 38674007 PMC: 11050645. DOI: 10.3390/ijms25084423.